Exact Mass: 664.3611

Exact Mass Matches: 664.3611

Found 41 metabolites which its exact mass value is equals to given mass value 664.3611, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Angiotensin (1-5)

Angiotensin I/II (1-5)

C30H48N8O9 (664.3544)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones COVID info from WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-butanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] 14-hydroxytetradecanoate

[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-butanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] 14-hydroxytetradecanoate

C32H56O14 (664.367)


   

(24R)-24-O-alpha-D-glucopyranosyl-27-nor-5alpha-cholestane-3beta,4beta,5,6alpha,7beta,8,14,15alpha,24-nonaol|typicusoside A

(24R)-24-O-alpha-D-glucopyranosyl-27-nor-5alpha-cholestane-3beta,4beta,5,6alpha,7beta,8,14,15alpha,24-nonaol|typicusoside A

C32H56O14 (664.367)


   

microtropioside C

microtropioside C

C32H56O14 (664.367)


   

microtropioside D

microtropioside D

C32H56O14 (664.367)


   

cyclo(-Gly-Ile-Phe-Leu-Tyr-Ala-)|dichotomin J

cyclo(-Gly-Ile-Phe-Leu-Tyr-Ala-)|dichotomin J

C35H48N6O7 (664.3584)


   

21-O-beta-D-xylopyranosyl-18S-hydroxydihydroprotolichesterinate 21-O-beta-D-glucopyranoside

21-O-beta-D-xylopyranosyl-18S-hydroxydihydroprotolichesterinate 21-O-beta-D-glucopyranoside

C32H56O14 (664.367)


   

wikstroelide Q

wikstroelide Q

C39H52O9 (664.3611)


   

callistenone D

callistenone D

C39H52O9 (664.3611)


   

17-benzoyloxy-3-O-(2,3-dimethylbutanoyl)-13-(2,3-dimethylbutanoyloxy)-20-deoxyingenol

17-benzoyloxy-3-O-(2,3-dimethylbutanoyl)-13-(2,3-dimethylbutanoyloxy)-20-deoxyingenol

C39H52O9 (664.3611)


   

Tyr Ala Glu Leu Arg

Tyr Ala Glu Leu Arg

C30H48N8O9 (664.3544)


   

Asp Phe Gln Lys Lys

Asp Phe Gln Lys Lys

C30H48N8O9 (664.3544)


   

3-decanoyl-3,4-di(3-methylbutanoyl)sucrose

3-decanoyl-3,4-di(3-methylbutanoyl)sucrose

C32H56O14 (664.367)


   

LQYKN

Leu Gln Tyr Lys Asn

C30H48N8O9 (664.3544)


   

DFQKK

Asp-Phe-Gln-Lys-Lys

C30H48N8O9 (664.3544)


   

OHOOA-PG

1-(9Z-octadecenoyl)-2-(5-hydroxy-8-oxo-6E-octenoyl)-sn-glycero-3-phospho-(1-sn-glycerol)

C32H57O12P (664.3587)


   

3-Decanoyl-3,4-di(isovaleryl)sucrose

3-Decanoyl-3,4-di(isovaleryl)sucrose

C32H56O14 (664.367)


   

Angiotensin-(1-5) dizwitterion

Angiotensin-(1-5) dizwitterion

C30H48N8O9 (664.3544)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

4-(dimethylamino)-N-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-16-[(1-methyl-4-imidazolyl)sulfonylamino]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

4-(dimethylamino)-N-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-16-[(1-methyl-4-imidazolyl)sulfonylamino]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbutanamide

C32H52N6O7S (664.3618)


   

(Z)-17-[(2R,3R,4S,5S,6R)-3-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-9-enoic acid

(Z)-17-[(2R,3R,4S,5S,6R)-3-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-9-enoic acid

C32H56O14 (664.367)


   
   
   

PG P-18:0/8:3;O3

PG P-18:0/8:3;O3

C32H57O12P (664.3587)


   

PG P-18:1/8:2;O3

PG P-18:1/8:2;O3

C32H57O12P (664.3587)


   

PG 14:0/12:3;O2

PG 14:0/12:3;O2

C32H57O12P (664.3587)


   

PG 14:1/12:2;O2

PG 14:1/12:2;O2

C32H57O12P (664.3587)


   
   
   
   
   

(3s,6s,9s,12s,15s)-12-benzyl-15-[(2s)-butan-2-yl]-6-[(4-hydroxyphenyl)methyl]-3-methyl-9-(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1,4,7,10,13,16-hexaene-2,5,8,11,14,17-hexol

(3s,6s,9s,12s,15s)-12-benzyl-15-[(2s)-butan-2-yl]-6-[(4-hydroxyphenyl)methyl]-3-methyl-9-(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1,4,7,10,13,16-hexaene-2,5,8,11,14,17-hexol

C35H48N6O7 (664.3584)


   

9a,11a-dimethyl-1-(5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-dodecahydrocyclopenta[a]phenanthren-3,3a,3b,4,5,5a,6,7-octol

9a,11a-dimethyl-1-(5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-dodecahydrocyclopenta[a]phenanthren-3,3a,3b,4,5,5a,6,7-octol

C32H56O14 (664.367)


   

(2s,3r,4s,5s,6r)-2-[(1s)-1-[(3r,4as,6as,8r,10ar,10bs)-3,4a,7,7,10a-pentamethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-[(1s)-1-[(3r,4as,6as,8r,10ar,10bs)-3,4a,7,7,10a-pentamethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C32H56O14 (664.367)


   

[(1s,4s,5s,6r,9s,10r,11r,12s,14r)-4,12-bis({[(2r)-2,3-dimethylbutanoyl]oxy})-5,6-dihydroxy-3,7,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl]methyl benzoate

[(1s,4s,5s,6r,9s,10r,11r,12s,14r)-4,12-bis({[(2r)-2,3-dimethylbutanoyl]oxy})-5,6-dihydroxy-3,7,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl]methyl benzoate

C39H52O9 (664.3611)


   

2-[1-(3,4a,7,7,10a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-3-yl)-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[1-(3,4a,7,7,10a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-3-yl)-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C32H56O14 (664.367)


   

2-[2-(3,4a,7,7,10a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-3-yl)-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[2-(3,4a,7,7,10a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-3-yl)-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C32H56O14 (664.367)


   

(1r,3s,3ar,3br,4s,5s,5as,6s,7s,9ar,9br,11ar)-9a,11a-dimethyl-1-[(2r,5r)-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-dodecahydrocyclopenta[a]phenanthren-3,3a,3b,4,5,5a,6,7-octol

(1r,3s,3ar,3br,4s,5s,5as,6s,7s,9ar,9br,11ar)-9a,11a-dimethyl-1-[(2r,5r)-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-dodecahydrocyclopenta[a]phenanthren-3,3a,3b,4,5,5a,6,7-octol

C32H56O14 (664.367)


   

(2r,3r,4s,5s,6r)-2-[(2s)-2-[(3r,4as,6as,8r,10ar,10bs)-3,4a,7,7,10a-pentamethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-[(2s)-2-[(3r,4as,6as,8r,10ar,10bs)-3,4a,7,7,10a-pentamethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-hydroxyethoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C32H56O14 (664.367)


   

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,3r,4s)-4-methyl-5-oxo-2-(14-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentadecyl)oxolane-3-carboxylate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,3r,4s)-4-methyl-5-oxo-2-(14-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentadecyl)oxolane-3-carboxylate

C32H56O14 (664.367)


   

12-benzyl-6-[(4-hydroxyphenyl)methyl]-3-methyl-9-(2-methylpropyl)-15-(sec-butyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1,4,7,10,13,16-hexaene-2,5,8,11,14,17-hexol

12-benzyl-6-[(4-hydroxyphenyl)methyl]-3-methyl-9-(2-methylpropyl)-15-(sec-butyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1,4,7,10,13,16-hexaene-2,5,8,11,14,17-hexol

C35H48N6O7 (664.3584)


   

{4,12-bis[(2,3-dimethylbutanoyl)oxy]-5,6-dihydroxy-3,7,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl}methyl benzoate

{4,12-bis[(2,3-dimethylbutanoyl)oxy]-5,6-dihydroxy-3,7,11,14-tetramethyl-15-oxotetracyclo[7.5.1.0¹,⁵.0¹⁰,¹²]pentadeca-2,7-dien-11-yl}methyl benzoate

C39H52O9 (664.3611)